A detailed history of Morgan Stanley transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Morgan Stanley holds 47,196 shares of SOPH stock, worth $153,858. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,196
Previous 60,077 21.44%
Holding current value
$153,858
Previous $275,000 37.45%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.19 - $4.8 $41,090 - $61,828
-12,881 Reduced 21.44%
47,196 $172,000
Q2 2024

Oct 17, 2024

BUY
$4.46 - $5.55 $60,343 - $75,091
13,530 Added 29.07%
60,077 $275,000
Q2 2024

Aug 14, 2024

BUY
$4.46 - $5.55 $60,343 - $75,091
13,530 Added 29.07%
60,077 $275,000
Q1 2024

Oct 17, 2024

SELL
$4.21 - $5.62 $56,961 - $76,038
-13,530 Reduced 22.52%
46,547 $229,000
Q1 2024

Aug 16, 2024

BUY
$4.21 - $5.62 $2,071 - $2,765
492 Added 1.07%
46,547 $229,000
Q1 2024

May 15, 2024

BUY
$4.21 - $5.62 $2,071 - $2,765
492 Added 1.07%
46,547 $229,000
Q4 2023

Aug 16, 2024

SELL
$2.5 - $4.87 $35,055 - $68,287
-14,022 Reduced 23.34%
46,055 $216,000
Q4 2023

Feb 13, 2024

SELL
$2.5 - $4.87 $5,490 - $10,694
-2,196 Reduced 4.55%
46,055 $216,000
Q3 2023

Nov 15, 2023

BUY
$2.3 - $4.58 $31,537 - $62,800
13,712 Added 39.7%
48,251 $122,000
Q2 2023

Aug 14, 2023

BUY
$3.84 - $5.3 $230 - $318
60 Added 0.17%
34,539 $154,000
Q1 2023

May 15, 2023

BUY
$1.98 - $5.49 $28,809 - $79,879
14,550 Added 73.01%
34,479 $171,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $2.98 $725,199 - $1.26 Million
-424,093 Reduced 95.51%
19,929 $41,000
Q3 2022

Nov 14, 2022

BUY
$2.63 - $5.1 $1.09 Million - $2.11 Million
413,267 Added 1343.74%
444,022 $1.17 Million
Q2 2022

Oct 27, 2022

BUY
$2.46 - $7.91 $20,730 - $66,657
8,427 Added 37.74%
30,755 $111,000
Q2 2022

Aug 15, 2022

BUY
$2.46 - $7.91 $20,730 - $66,657
8,427 Added 37.74%
30,755 $111,000
Q1 2022

Oct 27, 2022

SELL
$7.31 - $15.6 $61,601 - $131,461
-8,427 Reduced 27.4%
22,328 $173,000
Q1 2022

May 13, 2022

BUY
$7.31 - $15.6 $33,143 - $70,730
4,534 Added 25.48%
22,328 $173,000
Q4 2021

Feb 14, 2022

SELL
$12.35 - $18.8 $1.04 Million - $1.59 Million
-84,475 Reduced 82.6%
17,794 $251,000
Q3 2021

Nov 15, 2021

BUY
$15.18 - $19.77 $1.55 Million - $2.02 Million
102,269 New
102,269 $1.79 Million

Others Institutions Holding SOPH

About SOPHiA GENETICS SA


  • Ticker SOPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 64,153,700
  • Market Cap $209M
  • Description
  • SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...
More about SOPH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.